ADVIK LABORATORIES LTD. SHARE PRICE [LIVE]
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Dec 22 | Jun 22 |
|---|---|---|
| Promoters (Change:-0.00) | 35.89% | 35.89% |
| FIIs (Change:0.00) | 0% | 0% |
| Mutual Funds (Change:0.00) | 0% | 0% |
| Insurance Companies (Change:0.00) | 0% | 0% |
| Other DIIs (Change:0.58) | 0.58% | 0% |
| Non Institution (Change:-0.58) | 63.53% | 64.11% |
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in ADVIK LABORATORIES LTD.
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
ADVIKLA News
Frequently Asked Questions
Can I buy ADVIK LABORATORIES LTD. (ADVIKLA) shares?
How do I buy ADVIK LABORATORIES LTD. (ADVIKLA) from Angel One?
- Direct investment: You can buy ADVIK LABORATORIES LTD. (ADVIKLA) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to ADVIK LABORATORIES LTD. (ADVIKLA) shares.
In which sector do ADVIK LABORATORIES LTD. (ADVIKLA) belong?
About ADVIKLA
Today's live share price for ADVIK LABORATORIES LTD. is NSE: N/A, BSE: N/A with a current market capitalization of .
Advik Laboratories Limited is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical, generic, and over the counter drugs in various formulations. The company's generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic, antipyretic, and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfunction; gastrointestinal agents; sedatives; and other miscellaneous products. Advik Laboratories Limited has a technical collaboration with PFC Pharma Focus Ltd. The company is based in New Delhi, India. It also markets its products in the Middle East, South America, and Africa. Advik Laboratories Limited was promoted in the 1994 by Jain along with a group of dedicated professionals. The company commenced commercial production in 1997. In his leadership, the company has witnessed a fast growth rate, without compromise to quality. During the year 2003-2004, the company established their brand, Zin - Ten (an anti- allergic tablets) in the oversea market. During the year 2004-2005, the company launched the new marketing set up and necessary approvals were taken for the new range of product like Majispa, Robial, Chewfe-C, Stibomin, Wibatol, Wibatol-O, Twosum, and Arfagel. During the year 2005-2006, the company bagged Govt. supply contracts from Govt. of Andhra Pradesh and Kerala Govt. for supply of Paracetamol. The company executed both the contracts on time. During the year 2007-2008, the company compliance of current guidelines requires good amount of funds for modernization of its plant as per standards of WHO-GMP level.
Read more
